The Journal of Korean Diabetes

Search

Page Path

HOME
Search

Focused Issues

체중변동성과 당뇨병: 이은정; J Korean Diabetes. 2022;23(1):35-42. Published online March 31, 2022; DOI: https://doi.org/10.4093/jkd.2022.23.1.35

2021 당뇨병 진료지침: 심혈관질환 위험관리: 문민경; J Korean Diabetes. 2021;22(4):259-267. Published online December 31, 2021; DOI: https://doi.org/10.4093/jkd.2021.22.4.259
Cited By 1

Statement

당뇨병 환자에서 심혈관질환 위험도 평가: 김진화; J Korean Diabetes. 2021;22(3):168-173. Published online September 30, 2021; DOI: https://doi.org/10.4093/jkd.2021.22.3.168

Focused Issues

Glucagon-Like Peptide 1 수용체작용제 최신지견: 김혜진; J Korean Diabetes. 2021;22(2):126-133. Published online June 30, 2021; DOI: https://doi.org/10.4093/jkd.2021.22.2.126
Cited By 1

Sodium Glucose Cotransporter-2 억제제의 최신지견: 조동혁; J Korean Diabetes. 2021;22(2):113-125. Published online June 30, 2021; DOI: https://doi.org/10.4093/jkd.2021.22.2.113

설포닐유레아 최신지견: 김태년; J Korean Diabetes. 2021;22(2):105-112. Published online June 30, 2021; DOI: https://doi.org/10.4093/jkd.2021.22.2.105

메트포민의 최신지견: 홍상모; J Korean Diabetes. 2021;22(2):85-90. Published online June 30, 2021; DOI: https://doi.org/10.4093/jkd.2021.22.2.85

임신성 당뇨병의 심혈관계 위험도: 김경수; J Korean Diabetes. 2020;21(2):75-80. Published online June 2, 2020; DOI: https://doi.org/10.4093/jkd.2020.21.2.75

노인 당뇨병 환자의 심혈관질환 위험인자 관리: Sung Hoon Yu; J Korean Diabetes. 2019;20(4):233-238. Published online January 17, 2020; DOI: https://doi.org/10.4093/jkd.2019.20.4.233

당뇨병 주사제: Glucagon-Like Peptide-1 수용체작용제: Inkuk Lee, Eun Seok Kang; J Korean Diabetes. 2019;20(3):149-156. Published online October 2, 2019; DOI: https://doi.org/10.4093/jkd.2019.20.3.149

Sodium-Glucose Cotransporter 2 억제제의 심혈관 질환 예방 효과 유발 기전: Jae Han Jeon; J Korean Diabetes. 2019;20(2):81-86. Published online July 17, 2019; DOI: https://doi.org/10.4093/jkd.2019.20.2.81

Statement

제2형 당뇨병 환자의 혈당 관리: 2018년 미국/유럽 당뇨병학회 합의안 요약: Jeong Mi Kim, Sang Soo Kim; J Korean Diabetes. 2019;20(1):6-9. Published online April 4, 2019; DOI: https://doi.org/10.4093/jkd.2019.20.1.6

Opinion

관찰연구에서 확인된 SGLT2 억제제의 심혈관질환 예방효과: 한국인의 결과를 중심으로: Kyoung Hwa Ha, Dae Jung Kim; J Korean Diabetes. 2018;19(3):135-139. Published online October 5, 2018; DOI: https://doi.org/10.4093/jkd.2018.19.3.135

2018년 미국당뇨병학회 진료지침 속의 작지만 큰 변화: Jeong Hyun Park; J Korean Diabetes. 2018;19(2):71-75. Published online July 9, 2018; DOI: https://doi.org/10.4093/jkd.2018.19.2.71

Focused Issues

제2형 당뇨병 약제치료 지침 2017 개정안: Glucagon-Like Peptide-1 수용체작용제: Hyun Jin Kim; J Korean Diabetes. 2018;19(1):35-40. Published online April 13, 2018; DOI: https://doi.org/10.4093/jkd.2018.19.1.35

Volume 23, No. 1

The Journal of
Korean Diabetes

Print ISSN: 2233-7431
Online ISSN: 2714-0547

MOST VIEWED

1,199	A Position Statement of the Utilization and Support Status of Continuous Glucose Monitoring in Korea
5,655	Recent Guideline for the Management of Dyslipidemia in Patients with Diabetes
2,253	Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: Diagnosis and Treatment
1,779	A New Paradigm for Care Coordination of Patients with Diabetes Mellitus: Linkage and Application Strategies to Available Resources between the Hospital and the Community
1,743	Recent Perspective of Metformin

Editorial Office: 101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064 Fax: +82-2-714-9084 E-mail: diabetes@kams.or.kr

Copyright © 2022 by Korean Diabetes Association. All rights reserved.